Centene Corporation (CNC) - Stock Analysis
Last updated: Apr 25, 2026
Research Idea
Research content for general circulation. Not individualized advice.Ā Methodology & Disclosures
Managed-care momentum with policy catalyst: Q1 2026 adjusted EPS of $3.37 beat expectations and full-year 2026 guidance was raised to above $3.40 adjusted EPS, while finalized Medicare Advantage payment increases improved reimbursement sentiment.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ā¢ Weak Profitability ā¢ Strong Cash Flow ā¢ High Leverage CNC has massive scale and strong free cash flow, but persistently negative margins, weak returns, and leveraged balance sheet risk keep the investment case challenged.
Price Behavior
Key Price Behavior Insights: ā¢ Trend reversal ā¢ Higher highs ā¢ Breakout test Support Level: $38.00ā$39.00 Resistance Level: $41.50ā$42.00 CNC has turned from a weak downtrend into a strong recovery over the last month, with support near $38ā$39 and near-term resistance around $41.50ā$42.00, so the key test is whether it can hold gains and break higher.
Sentiment & News
Key News Insights: ā¢ Business restructuring ā¢ Margin pressure ā¢ Community investment Centene is restructuring operations and leadership while facing softer membership and higher medical-cost pressure ahead of earnings, even as it continues to highlight strong community investments and stock-style appeal.
AI Summary
CNC is shifting from a ābroken managed-careā story to a credible turnaround, with improving Medicaid trends, aggressive Marketplace repricing, and solid free cash flow/cash above debt, but the investment case still hinges on whether medical-cost normalization continues fast enough to turn fragile, policy-sensitive margin improvement into durable earnings rather than a short-lived bounce.
Description
Centene Corporation is a multinational healthcare company that provides programs and services primarily for under-insured and uninsured individuals in the U.S., delivering government-funded managed care across Medicaid, CHIP, long-term services and supports, foster care, and plans for dually eligible and disabled populations, alongside commercial insurance products. Its offerings span clinical and non-clinical care coordination, pharmacy and behavioral health services, telehealth and home-based care, and supplemental services for vision, dental and transportation; a separate specialty-services unit provides pharmacy benefits management, nurse advice lines, correctional and military health support, and related staffing. The company was founded in 1984 and is headquartered in St. Louis, Missouri.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 28 | May 5 | CNC | Centene Corporation | Managed-care momentum with policy catalyst: Q1 2026 adjusted EPS of $3.37 beat expectations and full-year 2026 guidance was raised to above $3.40 adjusted EPS, while finalized Medicare Advantage payment increases improved reimbursement sentiment. | Active | +0.0% |